Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2761 | 2079 | 41.9 | 84% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 261 | 18876 | PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ACTIVATED PROTEIN C | Author keyword | 163 | 49% | 12% | 240 |
| 2 | ENDOTHELIAL PROTEIN C RECEPTOR | Author keyword | 79 | 72% | 3% | 63 |
| 3 | DROTRECOGIN ALFA ACTIVATED | Author keyword | 77 | 73% | 3% | 58 |
| 4 | EPCR | Author keyword | 69 | 83% | 2% | 39 |
| 5 | XIGRIS | Author keyword | 65 | 95% | 1% | 21 |
| 6 | DISSEMINATED INTRAVASCULAR COAGULATION | Author keyword | 59 | 23% | 11% | 227 |
| 7 | ENDOTHELIAL CELL PROTEIN C RECEPTOR | Author keyword | 50 | 84% | 1% | 27 |
| 8 | PROTEIN C | Author keyword | 41 | 19% | 9% | 197 |
| 9 | RECOMBINANT HUMAN ACTIVATED PROTEIN C | Author keyword | 17 | 59% | 1% | 19 |
| 10 | DROTRECOGIN ALPHA | Author keyword | 15 | 88% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ACTIVATED PROTEIN C | 163 | 49% | 12% | 240 | Search ACTIVATED+PROTEIN+C | Search ACTIVATED+PROTEIN+C |
| 2 | ENDOTHELIAL PROTEIN C RECEPTOR | 79 | 72% | 3% | 63 | Search ENDOTHELIAL+PROTEIN+C+RECEPTOR | Search ENDOTHELIAL+PROTEIN+C+RECEPTOR |
| 3 | DROTRECOGIN ALFA ACTIVATED | 77 | 73% | 3% | 58 | Search DROTRECOGIN+ALFA+ACTIVATED | Search DROTRECOGIN+ALFA+ACTIVATED |
| 4 | EPCR | 69 | 83% | 2% | 39 | Search EPCR | Search EPCR |
| 5 | XIGRIS | 65 | 95% | 1% | 21 | Search XIGRIS | Search XIGRIS |
| 6 | DISSEMINATED INTRAVASCULAR COAGULATION | 59 | 23% | 11% | 227 | Search DISSEMINATED+INTRAVASCULAR+COAGULATION | Search DISSEMINATED+INTRAVASCULAR+COAGULATION |
| 7 | ENDOTHELIAL CELL PROTEIN C RECEPTOR | 50 | 84% | 1% | 27 | Search ENDOTHELIAL+CELL+PROTEIN+C+RECEPTOR | Search ENDOTHELIAL+CELL+PROTEIN+C+RECEPTOR |
| 8 | PROTEIN C | 41 | 19% | 9% | 197 | Search PROTEIN+C | Search PROTEIN+C |
| 9 | RECOMBINANT HUMAN ACTIVATED PROTEIN C | 17 | 59% | 1% | 19 | Search RECOMBINANT+HUMAN+ACTIVATED+PROTEIN+C | Search RECOMBINANT+HUMAN+ACTIVATED+PROTEIN+C |
| 10 | DROTRECOGIN ALPHA | 15 | 88% | 0% | 7 | Search DROTRECOGIN+ALPHA | Search DROTRECOGIN+ALPHA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DISSEMINATED INTRAVASCULAR COAGULATION | 107 | 19% | 25% | 515 |
| 2 | EPCR GENE | 62 | 75% | 2% | 45 |
| 3 | HUMAN BRAIN ENDOTHELIUM | 61 | 76% | 2% | 42 |
| 4 | PULMONARY VASCULAR INJURY | 45 | 62% | 2% | 47 |
| 5 | COLI SEPTIC SHOCK | 35 | 45% | 3% | 58 |
| 6 | PURPURA FULMINANS | 34 | 29% | 5% | 102 |
| 7 | REDUCED ANTICOAGULANT ACTIVITY | 31 | 92% | 1% | 12 |
| 8 | EPCR | 29 | 75% | 1% | 21 |
| 9 | BARRIER PROTECTION | 24 | 91% | 0% | 10 |
| 10 | THROMBIN THROMBOMODULIN COMPLEX | 23 | 45% | 2% | 39 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Inflammation and coagulation | 2010 | 162 | 119 | 69% |
| The cytoprotective protein C pathway | 2007 | 348 | 108 | 71% |
| Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway | 2013 | 30 | 105 | 63% |
| Endothelial cell protein C receptor: a multiliganded and multifunctional receptor | 2014 | 7 | 89 | 81% |
| Protein C anticoagulant system-anti-inflammatory effects | 2012 | 37 | 54 | 85% |
| The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation | 2013 | 13 | 56 | 75% |
| Expert consensus for the treatment of disseminated intravascular coagulation in Japan | 2010 | 42 | 37 | 76% |
| The effect of inflammation on coagulation and vice versa | 2011 | 31 | 36 | 64% |
| Disseminated intravascular coagulation: a review for the internist | 2013 | 10 | 37 | 76% |
| Bidirectional relation between inflammation and coagulation | 2004 | 338 | 68 | 37% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SUTTON ARTHRIT S | 15 | 88% | 0.3% | 7 |
| 2 | CARDIOVASC BIOL PROGRAM | 14 | 18% | 3.3% | 68 |
| 3 | VASC MED INTERNAL MED | 11 | 52% | 0.7% | 15 |
| 4 | COCHIN PORT ROYAL MED | 8 | 75% | 0.3% | 6 |
| 5 | SHIBATA HOSP | 8 | 100% | 0.2% | 5 |
| 6 | ACUTE CRIT CARE MEDKITA KU | 7 | 46% | 0.6% | 12 |
| 7 | ACUTE CRIT CARE MED | 7 | 39% | 0.6% | 13 |
| 8 | ROALD DAHL HAEMOSTASIS THROMBOSIS | 6 | 48% | 0.5% | 10 |
| 9 | ZENT ABT ANASTHESIOL INTENS MED | 6 | 80% | 0.2% | 4 |
| 10 | ANESTHESIOL CRIT CARE MEDKITA KU | 6 | 71% | 0.2% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000193449 | THROMBOMODULIN//SOLUBLE THROMBOMODULIN//PLASMA THROMBOMODULIN |
| 2 | 0.0000141389 | PURPURA FULMINANS//SYMMETRICAL PERIPHERAL GANGRENE//MENINGOCOCCAL SEPTICEMIA |
| 3 | 0.0000139896 | CAPSAICIN SENSITIVE SENSORY NEURONS//BIODEF MED//REPROD ENGN |
| 4 | 0.0000119876 | SPECIALTY CARE SERV//PULM CRIT CARE MEDMED//ANTIPLASMINS |
| 5 | 0.0000096572 | SURVIVING SEPSIS CAMPAIGN//SEVERE SEPSIS//EARLY GOAL DIRECTED THERAPY |
| 6 | 0.0000096279 | BURN EXCISION//ANTITHROMBIN III CONCENTRATE//BURN TRAUMA UNIT SURG |
| 7 | 0.0000087094 | PROTEIN S//PROTEIN C DEFICIENCY//C4B BINDING PROTEIN |
| 8 | 0.0000083971 | PROTEIN C INHIBITOR//MCFD2//F5F8D |
| 9 | 0.0000081205 | CHRONIC DISSEMINATED INTRAVASCULAR COAGULATION//ANTICOAGULANTS ADMINISTRATION AND DOSAGE//FEASIBLE STUDY |
| 10 | 0.0000079134 | TISSUE FACTOR//TISSUE FACTOR PATHWAY INHIBITOR//TFPI |